These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37414137)

  • 1. Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort.
    Perrot L; Boyer L; Flipo RM; Marotte H; Pertuiset E; Miceli C; Thomas T; Seror R; Chazerain P; Roux N; Richez C; Pham T;
    Joint Bone Spine; 2023 Dec; 90(6):105608. PubMed ID: 37414137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
    FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.
    Favalli EG; Selmi C; Becciolini A; Biggioggero M; Ariani A; Santilli D; Fusaro E; Parisi S; Massarotti M; Marchesoni A; Meroni PL
    Arthritis Care Res (Hoboken); 2017 Jun; 69(6):867-874. PubMed ID: 27696735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis.
    G S Saad C; S R Silva M; Sampaio-Barros PD; C B Moraes J; G Schainberg C; Gonçalves CR; Shimabuco AY; Aikawa NE; F N Yuki E; G Pasoto S; V K Kupa L; K Aoyama R; S R Araujo C; Silva CA; Medeiros-Ribeiro AC; Bonfa E
    Joint Bone Spine; 2023 Jan; 90(1):105464. PubMed ID: 36150668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug maintenance of a second tumor necrosis factor alpha inhibitor in spondyloarthritis patients: A real-life multicenter study.
    Krajewski F; Andras L; Pereira-Gillion C; Goupille P; Salliot C
    Joint Bone Spine; 2019 Nov; 86(6):761-767. PubMed ID: 31326602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence.
    Flouri ID; Markatseli TE; Boki KA; Papadopoulos I; Skopouli FN; Voulgari PV; Settas L; Zisopoulos D; Iliopoulos A; Geborek P; Drosos AA; Boumpas DT; Sidiropoulos P
    J Rheumatol; 2018 Jun; 45(6):785-794. PubMed ID: 29606666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort.
    Canouï-Poitrine F; Poulain C; Molto A; Le Thuaut A; Lafon C; Farrenq V; Ferkal S; Le Corvoisier P; Ghaleh B; Bastuji-Garin S; Fautrel B; Dougados M; Claudepierre P
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1395-402. PubMed ID: 24664935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
    Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.
    Eviatar T; Furer V; Polachek A; Zisman D; Peleg H; Elalouf O; Levartovsky D; Kaufman I; Broyde A; Haddad A; Feld J; Aassi M; Quebe-Fehling E; Alarcon I; Pel S; Paran D; Elkayam O
    J Rheumatol; 2024 Apr; 51(4):415-422. PubMed ID: 37914221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network.
    Raiker R; Pakhchanian H; Kavadichanda C; Gupta L; Kardeş S; Ahmed S
    Clin Rheumatol; 2022 Mar; 41(3):721-730. PubMed ID: 34837569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.
    Bourguiba R; Kyheng M; Koné-Paut I; Rouzaud D; Avouac J; Devaux M; Abdallah NA; Fautrel B; Ferreira-Maldent N; Langlois V; Ledoult E; Nielly H; Queyrel V; Sellam J; Tieulie N; Chazerain P; Evon P; Labreuche J; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
    RMD Open; 2022 May; 8(1):. PubMed ID: 35537796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis.
    Bello N; Etcheto A; Béal C; Dougados M; Moltó A
    Arthritis Res Ther; 2016 Feb; 18():42. PubMed ID: 26860612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
    Marques CDL; Ribeiro SLE; Albuquerque CP; de Sousa Studart SA; Ranzolin A; de Andrade NPB; Dantas AT; Mota GD; Resende GG; Marinho AO; Angelieri D; Andrade D; Ribeiro FM; Omura F; Silva NA; Rocha Junior L; Brito DE; Fernandino DC; Yazbek MA; Souza MPG; Ximenes AC; Martins ASS; Castro GRW; Oliveira LC; Freitas ABSB; Kakehasi AM; Gomides APM; Reis Neto ET; Pileggi GS; Ferreira GA; Mota LMH; Xavier RM; de Medeiros Pinheiro M;
    Adv Rheumatol; 2022 Nov; 62(1):45. PubMed ID: 36419163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases.
    Rivière E; Arnaud L; Ebbo M; Allanore Y; Claudepierre P; Dernis E; Ziza JM; Miceli-Richard C; Philippe P; Richez C; Soubrier M; Belkhir R; Seror R; Mariette X; Pavy S;
    J Rheumatol; 2017 Jul; 44(7):1011-1017. PubMed ID: 28412700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring.
    Cecconi M; Ranza R; Titton DC; Moraes JCB; Bertolo M; Bianchi W; Brenol C; Carvalho HM; de Castro GRW; Costa IP; Cunha MFL; Duarte Â; Fernandes V; Freire M; Louzada-Junior P; Macieira JC; Miranda JRS; Pereira IA; Pinheiro GRC; Stadler B; Toledo RA; Valim V; Descalzo MA; Pinto RMC; Laurindo I
    J Clin Rheumatol; 2020 Mar; 26(2):73-78. PubMed ID: 32073519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
    Hasseli R; Pfeil A; Hoyer BF; Krause A; Lorenz HM; Richter JG; Schmeiser T; Voll RE; Schulze-Koops H; Specker C; Müller-Ladner U
    Clin Exp Rheumatol; 2021; 39(3):639-647. PubMed ID: 33822706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
    Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
    Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry.
    Fernández-Carballido C; Sanchez-Piedra C; Valls R; Garg K; Sánchez-Alonso F; Artigas L; Mas JM; Jovaní V; Manrique S; Campos C; Freire M; Martínez-González O; Castrejón I; Perella C; Coma M; van der Horst-Bruinsma IE
    Arthritis Care Res (Hoboken); 2023 Jan; 75(1):115-124. PubMed ID: 36278846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study.
    Couderc M; Pereira B; Molto A; Tiple A; Soubrier M; Dougados M
    J Rheumatol; 2018 Jun; 45(6):795-801. PubMed ID: 29657148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.